period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.85,0.35,0.0,0.2916666666666667,[0],The FDA is aware of reports of potential manufacturer disruptions and is actively monitoring the situation. We encourage manufacturers to voluntarily report any anticipated production issues to facilitate timely responses.
1,1.5,0.85,0.65,0.0,0.43333333333333335,[0],The FDA acknowledges an emerging shortage of the specified drug due to manufacturer disruptions. We recommend stakeholders enhance reporting and coordination to mitigate impact. Patient safety remains our priority.
2,1.5,1.0,0.5,0.0,0.3333333333333333,[0],The FDA is closely monitoring the emerging drug shortage. We encourage manufacturers and stakeholders to engage in voluntary reporting to aid in coordination and resolution efforts.
3,1.3,1.0,0.30000000000000004,0.0,0.23076923076923078,[0],The FDA is currently monitoring an emerging shortage situation. We encourage manufacturers and healthcare providers to report any changes in supply trends to help ensure continued patient access.
